Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Polyunsaturated fatty acid production in heterologous organisms using PUFA polyketide synthase systems

a polyketide synthase and heterologous organism technology, applied in the field of polyunsaturated fatty acid production in heterologous organisms using pufa polyketide synthase systems, can solve the problems that the current supply of pufas from natural sources and from chemical synthesis is not sufficient for commercial needs, and achieves the effects of reducing competition for malonyl coa, increasing the level of malonyl coa, and reducing competition for malonyl co

Inactive Publication Date: 2007-10-18
SEMBIOSYS GENETICS INC +1
View PDF72 Cites 179 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

"The patent text describes isolated nucleic acid molecules and proteins that use PUFA-CoA as a substrate to form phospholipids or triacylglycerols. The nucleic acid molecules have a high degree of identity with certain amino acid sequences. The invention also includes genetically modified organisms that express these nucleic acid molecules or proteins. The technical effects of the invention include improved production of PUFAs and increased efficiency of PUFA utilization for the formation of phospholipids and triacylglycerols."

Problems solved by technology

However, the current supply of PUFAs from natural sources and from chemical synthesis is not sufficient for commercial needs.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polyunsaturated fatty acid production in heterologous organisms using PUFA polyketide synthase systems
  • Polyunsaturated fatty acid production in heterologous organisms using PUFA polyketide synthase systems
  • Polyunsaturated fatty acid production in heterologous organisms using PUFA polyketide synthase systems

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0408] This example describes the creation of a Schizochytrium FAS knockout strain for biochemical studies.

[0409]Schizochytrium contains a single large gene that encodes the FAS enzyme responsible for production of short chain saturated fatty acids (described in U.S. Patent Application Publication No. 20050191679 A1). A Schizochytrium FAS knock out (FAS-KO) construct was made using procedures described in U.S. Pat. No. 7,001,772. An ˜10.0 kB EcoRV fragment of genomic DNA containing most of the FAS Orf (from about 728 bp downstream of the presumed ATG start codon to about 680 bp downstream of the stop codon) was cloned into a Stratagene bluescript vector (pBSK) at the EcoRV site of the multiple cloning region. An ˜3.5 kB internal BglII fragment was removed from the cloned Schizochytrium DNA and replaced with an ˜1.1 kB BamHI fragment from pTubZeo11-2 containing a Zeocin resistance cassette (see U.S. Pat. No. 7,001,772, supra). The plasmid (pJK878) was introduced into a cell wall def...

example 2

[0410] The following example describes the general protocol for preparation of cell free extracts of Schizochytrium Ac66, and PUFA synthase KO and FAS-KO strains derived from Schizochytrium Ac66.

[0411] An example of a protocol for preparation of cell free homogenates (CFH) from the cell wall deficient strains of Schizochytrium is as follows. Cells were grown in A50-3 medium and then diluted into M2B medium. The media used for growing the KO strains were supplemented with the appropriate fatty acid. Cells were grown to an OD600 nm of >˜2.5 and 2. Samples were stored at −74° C. until needed.

example 3

[0412] This example describes the general conditions for in vitro FAS and PUFA synthase activity assays.

[0413] An example of a protocol for in vitro activity assays of both FAS and PUFA synthase activities is as follows. In a final volume of 100 uL, mix the enzyme preparation and Buffer A (volume of these 2 components=90 uL) plus the following components added as a cocktail (in 10 uL) to yield the final concentrations indicated in parenthesis: malonyl-CoA (50 uM—a mixture of cold and malonyl-2-14C-CoA such that the final concentration of radiolabel is 0.65 μCi / mL), NADH (1 mM), NADPH (1 mM) and acetyl-CoA (10 uM). These components and additional components can be adjusted depending on the requirements of the particular experiments. The assay reactions are carried out in glass tubes in a room temperature (˜21° C.) water bath. The time of incubation is dependant on the experimental requirements. The reactions are stopped by one of two methods depending on the work-up protocol. For co...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
temperaturesaaaaaaaaaa
melting temperaturesaaaaaaaaaa
temperatureaaaaaaaaaa
Login to View More

Abstract

Disclosed are novel acyl-CoA synthetases and novel acyltransferases, nucleic acid molecules encoding the same, recombinant nucleic acid molecules and recombinant host cells comprising such nucleic acid molecules, genetically modified organisms (microorganisms and plants) comprising the same, and methods of making and using the same. Also disclosed are genetically modified organisms (e.g., plants, microorganisms) that have been genetically modified to express a PKS-like system for the production of PUFAs (a PUFA PKS system or PUFA synthase), wherein the organisms have been modified to express an acyl-CoA synthetase, to express an acyl transferase, to delete or inactivate a fatty acid synthase (FAS) expressed by the organism, to reduce competition for malonyl CoA with the PUFA synthase or to increase the level of malonyl CoA in the plant or plant cell, and in one aspect, to inhibit KASII or KASIII. Additional modifications, and methods to make and use such organisms, in addition to PUFAs and oils obtained from such organisms, are disclosed, alone with various products including such PUFAs and oils.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] This application claims the benefit of priority under 35 U.S.C. § 119(e) from U.S. Provisional Application Ser. No. 60 / 784,616, filed Mar. 21, 2006, and from U.S. Provisional Application Ser. No. 60 / 783,205, filed Mar. 15, 2006. The entire disclosure of each of U.S. Provisional Application Ser. No. 60 / 784,616 and U.S. Provisional Application Ser. No. 60 / 783,205, filed Mar. 15, 2006 is incorporated herein by reference.FIELD OF THE INVENTION [0002] The present invention generally relates to the use of accessory proteins and targets to improve the production of polyunsaturated fatty acids (PUFAs) and particularly, long chain PUFAs (LCPUFAs), in a host organism that has been genetically modified with a PKS-like system for producing such PUFAs (i.e., a PUFA PKS system or a PUFA synthase). The present invention also relates to the organisms that have been genetically modified to express such accessory proteins or modified with respect to such...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A01H1/00C12N9/04C12N15/82C12N5/04A23L5/40A23L25/00
CPCC12N9/1029C12N9/93C12P7/6472C12P7/6427C12N15/8247A61P1/04A61P1/16A61P11/00A61P15/00A61P15/06A61P19/02A61P19/08A61P19/10A61P25/08A61P25/24A61P25/28A61P27/02A61P29/00A61P3/02A61P31/04A61P35/00A61P3/06A61P37/06A61P43/00A61P7/00A61P9/10C12N5/04C12N5/00C12P7/6432C12P7/6434Y02P20/52
Inventor METZ, JAMES G.KUNER, JERRY M.LIPPMEIER, JAMES CASEYMOLONEY, MAURICE MARTINNYKIFORUK, CORY LEE
Owner SEMBIOSYS GENETICS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com